Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study.
Jianling TaoOsamu Winget YasuiNeil S KamdarSijie ZhengRita A PopatDavid H RehkopfGlenn M ChertowPublished in: Kidney360 (2024)
During 2016-2020, plasmapheresis was deployed in approximately 20% of patients being admitted for AAV and acute kidney involvement in the US. As standards of care and practice evolve, the role of plasmapheresis in the management of AAV with acute kidney involvement will require further study.
Keyphrases
- liver failure
- healthcare
- end stage renal disease
- respiratory failure
- ejection fraction
- chronic kidney disease
- drug induced
- newly diagnosed
- quality improvement
- prognostic factors
- primary care
- palliative care
- gene therapy
- physical activity
- patient reported outcomes
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- affordable care act